Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,494 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,594 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00576472 | Learning Impairments Among Survivors of Childhood Cancer | completed | Phase 4 | 469 | St. Jude Children's Research HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT02988219 | Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method | completed | Phase 4 | 50 | Medical University of WarsawOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00872859 |
| The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial |
| completed |
| Phase 4 |
| 128 |
| University of UtahOTHER |
| 1 |
| May 18, 2017 |
| clinicaltrials |
| NCT01781299 | Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU | completed | Phase 4 | 9 | University of PittsburghOTHER | 1 | May 12, 2017 | clinicaltrials |
| NCT01783236 | Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery | completed | Phase 4 | 16 | Weill Medical College of Cornell UniversityOTHER | 1 | May 11, 2017 | clinicaltrials |
| NCT00176046 | Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study | completed | Phase 4 | 114 | Heidelberg UniversityOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00092183 | An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) | completed | Phase 4 | 866 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 5, 2017 | clinicaltrials |
| NCT01230905 | Study to Monitor the Effects of Androgen Suppression Treatment on the Heart(AST) | completed | Phase 4 | 181 | Ottawa Heart Institute Research CorporationOTHER | 1 | Apr 24, 2017 | clinicaltrials |
| NCT02140593 | The Laparotomy Study | completed | Phase 4 | 128 | Herlev HospitalOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT02728921 | The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery(AIR) | completed | Phase 4 | 70 | Region SkaneOTHER | 1 | Apr 19, 2017 | clinicaltrials |
| NCT00686543 | Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) | completed | Phase 4 | 75 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 7, 2017 | clinicaltrials |
| NCT01432015 | Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting | completed | Phase 4 | 20 | Gynecologic Oncology AssociatesOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT03084809 | Chemotherapy Combined With CIK Treating Colon Cancer | completed | Phase 4 | 46 | China Meitan General HospitalOTHER | 0 | Mar 21, 2017 | clinicaltrials |
| NCT02582970 | A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum | completed | Phase 4 | 40 | Hoffmann-La RocheINDUSTRY | 1 | Mar 9, 2017 | clinicaltrials |
| NCT00628147 | Clinical Evaluation of Narrow Band Imaging Colonoscope | completed | Phase 4 | 284 | VA Palo Alto Health Care SystemFED | 1 | Mar 8, 2017 | clinicaltrials |
| NCT00361140 | Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) | completed | Phase 4 | 72 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT01206088 | Tasigna in Glivec-resistant or Intolerant Patients in CML | completed | Phase 4 | 93 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 28, 2017 | clinicaltrials |
| NCT00434447 | Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases | completed | Phase 4 | 73 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 27, 2017 | clinicaltrials |
| NCT00470834 | Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy | completed | Phase 4 | 127 | GlaxoSmithKlineINDUSTRY | 2 | Feb 27, 2017 | clinicaltrials |
| NCT00237133 | Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women(PREDICT) | completed | Phase 4 | 112 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 24, 2017 | clinicaltrials |
| NCT00171899 | Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) | completed | Phase 4 | 80 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00237146 | Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy | completed | Phase 4 | 38 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00242554 | Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases | completed | Phase 4 | 150 | Novartis PharmaceuticalsINDUSTRY | 0 | Feb 23, 2017 | clinicaltrials |
| NCT00786812 | Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase(MACS0439) | completed | Phase 4 | 89 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00535652 | Concentration of Ertapenem in Colorectal Tissue | completed | Phase 4 | 23 | University of UlmOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT00334139 | Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | completed | Phase 4 | 411 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00372476 | Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer(INV181) | completed | Phase 4 | 33 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT02458573 | Comparison of the Effects of Continuous Epidural Analgesia and Continuous Intravenous Analgesia on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy | completed | Phase 4 | 86 | Yonsei UniversityOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT02441894 | Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer(PEGAZUS) | completed | Phase 4 | 21 | SanofiINDUSTRY | 1 | Jan 24, 2017 | clinicaltrials |
| NCT00375765 | Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer | completed | Phase 4 | 40 | GlaxoSmithKlineINDUSTRY | 1 | Jan 19, 2017 | clinicaltrials |
| NCT00363311 | Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men | completed | Phase 4 | 302 | GlaxoSmithKlineINDUSTRY | 2 | Jan 18, 2017 | clinicaltrials |
| NCT01571544 | The Use of Thermal Suits as Preventing Hypothermia During Surgery | completed | Phase 4 | 100 | Tampere University HospitalOTHER | 1 | Jan 4, 2017 | clinicaltrials |
| NCT03007212 | Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis | completed | Phase 4 | 30 | Ain Shams UniversityOTHER | 0 | Jan 2, 2017 | clinicaltrials |
| NCT01301729 | A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment | completed | Phase 4 | 32 | Hoffmann-La RocheINDUSTRY | 1 | Dec 29, 2016 | clinicaltrials |
| NCT00966277 | Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients | completed | Phase 4 | 87 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 12, 2016 | clinicaltrials |
| NCT01660906 | Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib | completed | Phase 4 | 39 | Bristol-Myers SquibbINDUSTRY | 5 | Nov 22, 2016 | clinicaltrials |
| NCT02782845 | An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) | completed | Phase 4 | 53 | Hoffmann-La RocheINDUSTRY | 2 | Nov 21, 2016 | clinicaltrials |
| NCT00172003 | Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis | completed | Phase 4 | 50 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00391690 | Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer | completed | Phase 4 | 99 | NovartisINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT01388907 | Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery | completed | Phase 4 | 61 | Medtronic - MITGINDUSTRY | 1 | Nov 17, 2016 | clinicaltrials |
| NCT01368523 | Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial | completed | Phase 4 | 19 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 16, 2016 | clinicaltrials |
| NCT02953730 | The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents | completed | Phase 4 | 9 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT02567331 | A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer | completed | Phase 4 | 28 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT02581423 | A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer | completed | Phase 4 | 63 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01701310 | IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia(IVICA) | completed | Phase 4 | 116 | Nottingham University Hospitals NHS TrustOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT01041612 | Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi | completed | Phase 4 | 120 | Taewoong Medical Co., Ltd.INDUSTRY | 2 | Oct 21, 2016 | clinicaltrials |
| NCT02597582 | LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients | completed | Phase 4 | 41 | Taichung Veterans General HospitalOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT00220194 | A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer | completed | Phase 4 | 100 | San Bernardino Urological Associates Medical Group IncOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT00845221 | Glivec in Pediatric Chronic Myeloid Leukemia (CML) | completed | Phase 4 | 44 | Poitiers University HospitalOTHER | 1 | Oct 11, 2016 | clinicaltrials |
Data updated 23 days agoSource updated May 30, 2017source: clinicaltrials